Billionaires Back Antismoking Effort
Gates and Bloomberg are pouring $500 million into a global effort to cut smoking. The effort gives Bloomberg a powerful ally in his tobacco fight, which started in 2002 in New York City.
Statin Study Could Lead to Gene Test
Scientists may have found a way to test for and possibly avoid the most serious side effect of cholesterol-lowering statin drugs, one of the top-selling medicines in the world.
Strong Sales Boost Drug Makers
Eli Lilly and Bristol-Myers reported improved second-quarter profits, helped by increased sales of drugs that treat cancer, mental illness and cardiovascular disease.
Pfizer's Net Rises on Global Sales
Pfizer's profit more than doubled as international sales offset generic competition in the U.S. Glaxo posted a 3% drop in net and will cut costs.
Membership Decline Hurts WellPoint
WellPoint's net fell 10%, and the health insurer cut its outlook. Shares rose on the better-than-expected results.
THE DOCTOR'S OFFICE By BENJAMIN BREWER, M.D.
Tough Times Prompt Patients to Skip Care
Increasing prices for just about everything are forcing some hard choices about health. Care that doesn't strike patients as critical is getting delayed. As the economy squeezes Dr. Brewer's patients, they are showing up sicker.
Viagra May Help Women
A study found that Pfizer's erectile-dysfunction drug Viagra can reduce adverse sexual effects in women caused by antidepressant use.
Salmonella Outbreak Exposes Safety Flaws
Federal investigators encountered hurdles that stymied their probe into the salmonella outbreak, including poor record-keeping, overwhelmed state health departments and the fact that jalapeños had never before been implicated.
Ranbaxy House Probe Questions FDA's Role
Leaders of a House committee said an investigation into whether Ranbaxy Laboratories fraudulently imported unsafe drugs into the country raises questions about the FDA's role in the allegations.
Drug Sales Boost Biogen's Net
Biogen Idec posted an 11% rise in second-quarter net income Tuesday on strong sales of multiple-sclerosis drugs Avonex and Tysabri and the company also boosted its 2008 outlook.
UnitedHealth's Results Spur Hope
UnitedHealth posted a 73% drop in net on charges tied to settling options-backdating cases. Its shares rose 10%.